comprehensive -WSS

comprehensive

author：comprehensive 2025-09-29 16:45:52 - browse：5

Why are rich biotechs cutting costs? Has JPM Week already worn off? And what’s going to move markets in 2024?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Jason Mast joins us to discuss an emerging trend in biotech: Cash-rich startups are laying off employees and tweaking their strategies amid a tough market for venture capital. We also look ahead to the biggest biotech stories coming in 2024, including some major data readouts and a few pivotal FDA decisions.

For more on what we cover, here’s the news on Dewpoint Therapeutics; here’s more on biotech in 2024; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Cancer drug shortages should be causing more outrage
Next article： What nurses really want: sufficient staffing for patient care

WSS

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

Study: AI not yet building 'n

Judge denies Trump's request for new trial in E. Jean Carroll case

Brain worms: The science behind RFK Jr.'s parasitic infection

H5N1 bird flu: what we're starting to learn about infection in cows

Stanford president’s abrupt resignation sparks debate

explore

comprehensive

leisure time

Trump demands the U.S. pay no more for drugs than other countries … again

H5N1 bird flu: what we're starting to learn about infection in cows

Cancer drug shortages should be causing more outrage

Dairy farmers resist CDC push for PPE against bird flu virus

ChatGPT in medicine: STAT answers readers' burning questions

Study: People of West African ancestry at greater risk of cardiac amyloidosis

In age of alternative facts, a scholarly course on calling out crap

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Telehealth startups turn to complex chronic diseases

entertainment

Dairy farmers resist CDC push for PPE against bird flu virus

Software glitch causes Tandem insulin pump to shutdown, FDA warns

Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

Researchers on aging grapple with how to calculate biological age

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

'CMA Fest' 2023: How to watch, who is performing and more

hotspot

Wikipedia

hotspot

focus